Cardiac dysfunction and mortality in critically ill patients with COVID-19: A Swedish multicentre observational study.

ABSTRACT:

Background

The prevalence and importance of cardiac dysfunction in critically ill patients with COVID-19 in Sweden is not yet established. The aim of the study was to assess the prevalence of cardiac dysfunction and elevated pulmonary artery pressure (PAP), and its influence on mortality in patients with COVID-19 in intensive care in Sweden.

Methods

This was a multicentre observational study performed in five intensive care units (ICUs) in Sweden. Patients admitted to participating ICU with COVID-19 were examined with echocardiography within 72 h from admission and again after 4 to 7 days. Cardiac dysfunction was defined as left ventricular (LV) dysfunction (ejection fraction <50% and/or regional hypokinesia) or right ventricular (RV) dysfunction (defined as TAPSE <17 mm or

SUBMITTER: Holmqvist J 

PROVIDER: S-EPMC9111275 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature